Purchase Order 75N91023P00737
Award Date
9/25/23
Potential Completion Date
9/24/24
Potential Value
$87K
Federal Agency
National Cancer Institute
Ultimate Awardee
Laboratory Corporation Of America Holdings
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Madison, WI 53704, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $33,932.40 firm-fixed-price delivery order awarded by the National Cancer Institute (NCI), part of the Department of Health and Human Services (HHS), to Guidehouse Digital LLC. The objective is to perform laboratory testing for the LMB-100 drug product, which is required by the Food and Drug Administration (FDA) for approval to conduct clinical trials with LMB-100 in human cancer patients. This delivery order was issued under the NCI's Scientific, Operations and Administrative...
This is a Cost Plus Fixed Fee delivery order contract awarded by the National Cancer Institute (NCI) to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract is for Good Manufacturing Practice (GMP) manufacturing of the LMB-2 immunotoxin, with a ceiling value of $1,021,037.00 and a performance period ending on September 24, 2025. The contract is not set aside for any specific socioeconomic category. Leidos Biomedical Research Inc. is an established Federally...
This federal contract award to Labcorp Early Development Laboratories Inc., a subsidiary of Laboratory Corporation of America Holdings, is a firm fixed-price delivery order contract awarded by the Northeast Area of a civilian federal agency. The contract, which has a ceiling value of $165,447.00, is for a variety of laboratory testing and analytical services, including stability testing, potency and safety assays, polyclonal antibody production, and pharmacokinetics testing for various...
This is a $5,273,743 firm fixed-price definitive contract awarded by the Office of Logistics and Acquisition Operations, a civilian agency, to Labcorp Early Development Laboratories Inc., a subsidiary of Laboratory Corporation of America Holdings. The contract does not have a set-aside designation. Under this contract, Labcorp will provide a range of laboratory testing and analytical services to support the federal government, including stability testing, potency and safety assays for drug...
This $14,800 firm fixed-price purchase order was awarded on December 28, 2024 by the National Cancer Institute, a civilian agency, to Leinco Technologies, Inc., a self-certified small disadvantaged business manufacturer of goods. The contract is for laboratory testing services and has a period of performance through December 27, 2025. Leinco Technologies has previously served as a subcontractor to Battelle Memorial Institute, providing specialized antibodies and reagents for SARS-CoV-1 and...
This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH), to Medical Science & Computing, LLC. The contract provides stability testing support services for the LMB-100 drug product. The contract has a ceiling value of $85,611.90 and a period of performance ending on May 22, 2023. This award was not set aside for small businesses. Medical Science & Computing, LLC is a for-profit limited liability...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $21,700 purchase order to Somalogic Operating Co., Inc. doing business as CM Life Sciences II Inc. for laboratory testing services. The firm fixed price contract runs from January 5, 2024 through July 15, 2024 and will be performed in Boulder, Colorado. No additional details were provided regarding the scope of laboratory testing services requested under the solicitation. The award was...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $1,649,757 delivery order contract to Leidos Biomedical Research Inc. for drug product formulation development, Good Manufacturing Practice manufacture, and long-term stability studies of BITOX for Phase I clinical trials. The prime contractor, Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc., will perform the work at its location in Fort Detrick, Maryland over a...
The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $24,500 purchase order to Somalogic Operating Co., Inc. doing business as CM Life Sciences II Inc. for laboratory testing services. The firm fixed price contract runs from September 1, 2023 through February 29, 2024 and will be performed in Boulder, Colorado. No additional details were provided regarding the scope of laboratory testing services requested under the...
This federal contract award, with an ID of 75N91023D00010|75N91024F00001, was issued by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services. The contract, which is not set aside, has a ceiling value of $1,866,116.00 and a completion date of September 17, 2026. The scope of the contract includes the production of a drug substance, conversion of the drug substance to a drug product, filling the drug product into applicators for clinical...